Immunmodulatorische Stufentherapie der Multiplen Sklerose
- 1 December 2006
- journal article
- Published by Springer Nature in Der Nervenarzt
- Vol. 77 (12) , 1506-1518
- https://doi.org/10.1007/s00115-006-2220-x
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating eventJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled studyThe Lancet Neurology, 2006
- Natalizumab and PMLNature Neuroscience, 2005
- The efficacy of glatiramer acetate in beta-interferon-intolerant MS patientsActa Neurologica Scandinavica, 2005
- Anti-adhesion therapiesCurrent Opinion in Pharmacology, 2005
- Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosisThe Lancet Neurology, 2005
- Mycophenolate mofetil and neurological diseasesLupus, 2005
- MitoxantroneCNS Drugs, 2004
- Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trialsNeurological Sciences, 2003
- Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapyMultiple Sclerosis Journal, 2001